<img src="https://secure.leadforensics.com/125032.png" alt="" style="display:none;">
Chase final_logo

Commercialisation partner to UK life sciences, providing specialist commercial, medical and talent solutions

shutterstock_582891865-1
Chase Logo White png-2

Vespa Capital is a business which holds similar beliefs, business practices and ethics to Chase. The investment by Vespa Capital has enabled Chase to incentivise key personnel moving forward and will allow us to accelerate our growth by investing in adjacent products and services.

Chris Phillips, co-founder at CHASE

Business Profile

CHASE is a specialist provider of outsourced commercial, medical and talent solution services to pharmaceutical, biotech and healthcare companies in the UK. It is the clear quality leader in the UK market, facilitating greater engagement and access between the life sciences industry and healthcare providers.

Across its six divisions, CHASE provides services ranging from strategic brand support, supplementation and enhancement of customer-facing capabilities, optimising outcomes for patients and healthcare providers, and specialist talent placement.

CHASE deploys hundreds of specialist outsourced staff to the commercial and medical divisions of its UK life sciences customers.

Visit CHASE
Investment Date
July 2016
Employees
300+
Founded
1998
Sector
Life Sciences
gettyimages-1062184620-1

Key Strengths

Vespa Capital invested in CHASE in July 2016 attracted by its international blue chip customer base, its strong reputation within its industry in the UK, and the strength of its customer relationships. Since partnering with the business, Vespa Capital has supported the management team to develop new service lines and successfully implemented a transition of the management of the business from the founders to a first-class management team.

  • In 2022 CHASE completed the strategic acquisition of Medacy, expanding CHASE’s offering to include the provision of quality pharmacist-led clinical services to the NHS.

  • The addition of Medacy also strengthens the group’s capabilities in collaborative working solutions for the existing pharmaceutical client base by adding remote patient reviews and utilising Medacy’s NHS network and expertise.

  • Strong management team with extensive industry experience within CHASE’s chosen markets.

  • Unique synergistic business model and candidate intelligence allows the business to source high quality personnel quicker than the competition.

  • Recognised as a quality leading provider of talent solution services via a number of industry awards.

  • A high proportion of long term, recurring revenue which provides future revenue visibility.

  • Very high levels of customer satisfaction and repeat business, driven by CHASE’s quality-led service model, as well as the diligent and ethical approach demonstrated by both CHASE’s operational staff and the team of contract personnel currently deployed.

  • Attractive growth opportunities unlocked in adjacent markets, through enhanced service offerings to existing customers and the development of new services lines.

What our clients say

Vespa Capital is a business which holds similar beliefs, business practices and ethics to Chase. The investment by Vespa Capital has enabled Chase to incentivise key personnel moving forward and will allow us to accelerate our growth by investing in adjacent products and services. Additionally, Chase will maintain its current quality offering which differentiates us from other CSOs.

What our clients say